Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Watch this keynote presentation from the Variant to Function (V2F) Symposium at the Broad Institute, where Robert Plenge, Executive Vice President and Chief Research Officer at Bristol Myers Squibb, delivers his talk titled "Placing billion-dollar bets: human genetics in drug R&D." Explore how human genetics is revolutionizing pharmaceutical research and development, particularly in making high-stakes investment decisions for drug discovery and development. Learn about the critical role of genetic associations in identifying actionable therapeutic targets and how genomic insights are being translated into practical applications for patient stratification through biomarkers and assays. Gain insights from a leading industry executive on the intersection of human genetics and pharmaceutical innovation, understanding how genetic data informs billion-dollar investment decisions in the drug development pipeline. This presentation is part of a comprehensive symposium hosted by the Novo Nordisk Foundation Center for Genomic Mechanisms of Disease, focusing on translating genetic discoveries into therapeutic advances and genetically-informed approaches in healthcare.
